Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

811
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
811
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

901
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
901
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Posttuberculosis Lung Disease in Adolescents in Lima, Peru.

Pediatrics·2026
Same author

Post-release tuberculosis risk among formerly incarcerated populations in Lima Peru.

Nature communications·2026
Same author

Prevalence and clinical implications of Aspergillus infection among tuberculosis patients in Peru.

The Journal of infection·2026
Same author

Building EVA (<i>Educación, Vinculación, y Autoayuda</i>): Tutorial for the Development of a Digital Mental Health Chatbot for Adolescents Living With HIV.

Journal of medical Internet research·2026
Same author

Quantifying within-household tuberculosis transmission: a systematic review and prospective cohort study.

International journal of epidemiology·2026
Same author

Transmissibility and Disease Progression of Asymptomatic Mycobacterium tuberculosis Infection, Lima, Peru.

Emerging infectious diseases·2026
Same journal

Somatosensory cortex shapes perceptual decision bias via the superior colliculus.

Research square·2026
Same journal

Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

Research square·2026
Same journal

Supporting Implementation of the National Standards for Cancer Survivorship Care: Development of the Cancer Survivorship Maturity Model (CSMM).

Research square·2026
Same journal

Operationalizing a walking exercise prescription based on 6-minute walk test results.

Research square·2026
Same journal

Age but not sex modifies lymphoid immune responses in murine sepsis.

Research square·2026
Same journal

Indirect effect, through aspects of neighborhood affluence and racial/ethnic composition, of receiving a Section 8 voucher on the prevalence of psychiatric disorders among boys and girls in the Moving to Opportunity study.

Research square·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.2K

The Hidden Epidemic: Post-Release Tuberculosis Risk in Formerly Incarcerated Populations.

Megan Murray1, Chuan-Chin Huang2, Meredith Brooks3

  • 1Harvard Medical School.

Research Square
|November 24, 2025
PubMed
Summary
This summary is machine-generated.

Incarceration significantly increases tuberculosis (TB) severity and poor treatment outcomes. This elevated risk and TB infection prevalence persist after release, highlighting prisons as TB reservoirs.

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K
Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

22.2K

Related Experiment Videos

Last Updated: Jan 10, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.2K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K
Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

22.2K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Incarcerated populations have a disproportionately high risk of tuberculosis (TB).
  • Limited understanding exists regarding the post-release persistence of this elevated TB risk in the community.

Purpose of the Study:

  • To investigate the long-term impact of incarceration on tuberculosis (TB) risk and treatment outcomes.
  • To assess TB infection prevalence among household contacts of individuals with a history of incarceration.

Main Methods:

  • Prospective cohort study of 3,666 TB patients and 7,101 household contacts in Lima, Peru.
  • Analysis of incarceration history, disease severity, treatment outcomes, and TB infection prevalence.
  • Comparison between individuals with and without a history of incarceration.

Main Results:

  • Individuals with incarceration history had more severe TB disease (mean score difference = 0.25) and a 2.17 times higher risk of poor treatment outcomes.
  • Nearly 73% of TB patients with known incarceration dates were diagnosed within two years of release, suggesting prison-acquired infections.
  • Household contacts with incarceration history showed a 1.33 times higher prevalence of TB infection, even for short incarceration periods (≤ 3 months).

Conclusions:

  • Incarceration significantly impacts TB dynamics, leading to more severe disease, worse outcomes, and increased household infection risk post-release.
  • Prisons function as critical reservoirs amplifying TB epidemics.
  • Integrated TB control strategies bridging prison and community health systems are urgently needed.